Press Release: ASCO : Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite's anti-Cancer Drug Namodenoson
Can-Fites data will be presented at the 2025 ASCO Gastrointestinal Cancers Symposium Can-Fite enrolls patients for its pivotal Phase...
Read full article »
ASCO is a Virginia-based nonprofit organization that represents and promotes physicians and oncology professionals caring for people with cancer.
Read more